why choose us

300×250 Ad Slot

Research Article: A Novel Inflammatory-Nutritional Prognostic Scoring System for Patients with Diffuse Large B Cell Lymphoma

Date Published: 2024-01-03

Introduction:
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin’s lymphoma. Although complete remission is achieved in % of DLBCL patients with initial standard treatment, about –% will relapse or develop refractory disease, which remains a serious challenge. In addition, according to gene expression profiling, DLBCL could be divided into two primary subtypes: germinal center B-cell-like (GCB) and activated B-cell-like (ABC). Patients with ABC DLBCL generally experience a worse prognosis. The…

Read more

300×250 Ad Slot